In this free webinar, learn how integrated technology and coordinated operational oversight can support diabetes clinical trial execution. The featured speakers will discuss the use of continuous glucose monitoring, blood glucose monitoring, eDiaries and electronic patient-reported outcomes across type 1 and type 2 diabetes programs. Attendees will also explore how stronger coordination across sites, technologies and data sources can reduce operational complexity and support reliable study data.
TORONTO, Oct. 26, 2026 /PRNewswire/ -- The diabetes clinical trial landscape is evolving rapidly. As type 1 diabetes programs expand and innovative therapies, including cell and gene therapies, move into clinical development, sponsors face increasing operational complexity. At the same time, digital technologies such as continuous glucose monitoring (CGM), blood glucose monitoring (BGM), eDiaries and ePROs are generating significant volumes of patient data. The challenge is no longer simply collecting data but integrating these technologies into a study strategy that delivers high-quality, reliable outcomes. This webinar will explore practical approaches to executing modern diabetes clinical trials by combining therapeutic expertise with coordinated operational oversight.
Using examples from type 1 diabetes while drawing on broader experience across type 2 diabetes and other metabolic indications, the featured speakers will discuss how sponsors can successfully implement digital technologies without increasing operational burden.
Attendees will gain practical insights into overcoming common operational challenges, improving data quality and designing diabetes studies that are better positioned for successful execution. Whether planning an early-phase proof-of-concept study or a global pivotal program, participants will gain actionable strategies for navigating the increasing complexity of today's diabetes clinical trial environment.
Register for this webinar to learn how operational oversight can support reliable data, integrated technology and successful diabetes clinical trial execution.
Join experts from Medpace, Ruchi Bhabhra, MBBS, PhD, Medical Director; Eric Klett, MD, Medical Director; Salvatore Zabbatino, MD, Sr. Director, Core Laboratories; Lauren Brown, MSc, Associate Director, Clinical Trial Management; and Amanda Burton, MSN, APRN, FNP-BC, Advanced Clinical Practitioner, for the live webinar on Monday, November 9, 2026, at 10am EST (4pm CET / EU-Central).
For more information, or to register for this event, visit Advancing Diabetes Clinical Trials Through Integrated Technology and Operational Oversight.
ABOUT XTALKS
Xtalks – The Life Science Community™ empowers professionals across pharma, biotech, medtech, healthcare and research with the trusted knowledge and collaborative insights that move the industry forward. Powered by Honeycomb Worldwide Inc., Xtalks delivers news, feature articles, webinars, podcasts, videos, expert interviews, curated job opportunities and more designed to support informed decision-making in a fast-evolving sector.
Every year, thousands of professionals rely on Xtalks for timely intelligence, peer perspectives and industry thought leadership. Join our life science community to stay informed, connected and ready for what's next.
To learn more about Xtalks, visit www.xtalks.com
For information about working with Xtalks to host your webinar, visit https://xtalks.com/partner-with-us/
Contact:
Soumya Shashikumar
Tel: +1 (416) 977-6555 x371
Email: [email protected]
SOURCE Xtalks


Share this article